Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sensus Healthcare (SRTS) Gains from Investment Securities (2017 - 2025)

Sensus Healthcare (SRTS) has 9 years of Gains from Investment Securities data on record, last reported at -$161000.0 in Q4 2025.

  • For Q4 2025, Gains from Investment Securities fell 359.68% year-over-year to -$161000.0; the TTM value through Dec 2025 reached -$200000.0, down 6.38%, while the annual FY2025 figure was $5000.0, 97.44% down from the prior year.
  • Gains from Investment Securities reached -$161000.0 in Q4 2025 per SRTS's latest filing, down from $200223.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $1.2 million in Q1 2023 and bottomed at -$1.3 million in Q2 2023.
  • Average Gains from Investment Securities over 5 years is $80630.6, with a median of $103259.0 recorded in 2021.
  • Peak YoY movement for Gains from Investment Securities: skyrocketed 664.45% in 2021, then crashed 359.68% in 2025.
  • A 5-year view of Gains from Investment Securities shows it stood at $97884.0 in 2021, then skyrocketed by 214.66% to $308000.0 in 2022, then tumbled by 70.93% to $89550.0 in 2023, then tumbled by 30.76% to $62000.0 in 2024, then plummeted by 359.68% to -$161000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Gains from Investment Securities were -$161000.0 in Q4 2025, $200223.0 in Q2 2025, and -$36000.0 in Q1 2025.